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MSY2 is implicated in regulating the stability and translation of maternal mRNAs during mouse oogenesis. We report here that by driving
the expression of a transgene encoding an Msy2 hairpin dsRNA in growing oocytes using the oocyte-specific Zp3 promoter, the amount of
MSY2 protein was reduced by at least 60% in fully grown oocytes. The decrease appeared specific because no decrease was observed in
either non-targeted mRNAs or proteins. Fertility of transgenic females was severely reduced. Although transgenic eggs could be inseminated,
the eggs did not exhibit the normal series of oscillations in intracellular Ca2+, resume meiosis, undergo cortical granule exocytosis, or ZP2
cleavage to ZP2f. Transgenic oocytes also displayed a higher incidence of both the non-surrounded nucleolus chromatin morphology, and
abnormal meiotic spindle formation was observed following oocyte maturation. Transgenic oocytes contained less total mRNA
(approximately 75–80% that of non-transgenic oocytes) and displayed a reduced level of protein synthesis. Moreover, several of the
maturation-associated changes in protein synthesis failed to occur in the transgenic oocytes. These results support a role for MSY2 in
stabilizing maternal mRNAs in growing oocytes, a process essential to generate meiotically and developmentally competent oocytes.
D 2004 Elsevier Inc. All rights reserved.Keywords: Msy2; Transgenic RNAi; Protein synthesis; Oocyte maturation; Egg activation; mRNA stabilityIntroduction
The two interactive processes that occur during oogen-
esis, that is, oocyte growth and meiosis, result in forming
a fully grown oocyte capable of meiotic maturation,
fertilization, and development to term (Schultz, 1986).
These processes, in particular oocyte maturation, depend
on the timely recruitment of maternal mRNAs. Mamma-
lian oocytes accumulate large quantities of maternal
mRNAs during their prolonged growth phase (approxi-
mately 20 days in mouse); the fully grown mouse oocyte
contains about 80 pg of total mRNA (Bachvarova et al.,
1985). These maternal mRNAs are very stable in growing
oocytes with a half-life of 8–12 days (Brower et al.,
1981). Mechanisms that regulate the stability and transla-
tion of these maternal mRNAs, however, are not well0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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material.
In non-mammalian oocytes, Y-box proteins are the major
components that package maternal mRNAs into ribonucleo-
protein particles (mRNPs), which suggests a role for these
proteins in regulating the stability and translation of mater-
nal mRNAs (Sommerville, 1999; Wolffe, 1994). MSY2 is a
very abundant mouse germ cell-specific Y-box protein
(approximately 2% of total oocyte protein) (Yu et al.,
2001). Its accumulation during oocyte growth and degrada-
tion by the mid two-cell stage, which coincides with the
massive degradation of maternal mRNAs, supports the
hypothesis that MSY2 regulates the stability and translation
of maternal mRNAs (Yu et al., 2001). Consistent with this is
that recombinant MSY2 protein binds to mRNAs in vitro
with relatively little sequence specificity, despite a prefer-
ence for certain short RNA sequences (UACCACAUCCACU)
(Davies et al., 2000; Giorgini et al., 2001; Yu et al., 2002)
and it can moderately repress the translation in vitro of
mRNAs at a physiologically relevant protein/mRNA molar
ratio (73:1) (Yu et al., 2002). Moreover, most of the MSY2
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tion. This association, which requires the RNA-binding
activity, could sequester maternal mRNAs and contribute
to their stability (Yu et al., 2003). Although these data
indicate that MSY2 likely plays a global role in the
regulation of the stability and translation of maternal
mRNAs during mouse oogenesis, the function of MSY2
in vivo remains unknown.
RNAi is a conserved cellular mechanism in which
double-stranded RNA (dsRNA) is processed into 21-
to 23-nt-long short interfering (si) duplex RNAs by a
RNaseIII-like enzyme (Dicer). These siRNAs are then
assembled into a large complex (RISC) that promotes the
sequence-specific destruction of the targeted mRNA
(Bosher and Labouesse, 2000; Hutvagner and Zamore,
2002). RNAi operates in different systems including mouse
oocytes and early embryos (Svoboda et al., 2000; Wianny
and Zernicka-Goetz, 2000). RNAi likely serves as a defense
mechanism against viral infections, in transgene silencing,
and in inhibiting transposon activity (Caplen et al., 2002;
Fagard et al., 2000; Pal-Bhadra et al., 2002; Sijen and
Plasterk, 2003; Tabara et al., 1999). Both long dsRNAs
and siRNAs have been used to reduce mRNA expression as
an efficient way to study gene function. Successful trans-
genic RNAi where the dsRNA is expressed from a transgene
has been reported in C. elegans, Drosophila, and Arabi-
dopsis (Chuang and Meyerowitz, 2000; Kennerdell and
Carthew, 2000; Tavernarakis et al., 2000), and we recently
demonstrated that transgenic RNAi can be used to study
gene function in mouse oocytes (Fedoriw et al., 2004; Stein
et al., 2003b).
We report here that the oocyte-specific Zp3 promoter-
mediated expression of Msy2 hairpin dsRNA through trans-
genesis specifically reduces the amount of MSY2 protein by
at least 60% in fully grown mouse oocytes. Decreased Msy2
expression results in abnormal meiotic spindle formation
and a low incidence of egg activation, which leads to a
markedly decreased litter size. Moreover, this reduction in
the amount of MSY2 protein results in a decrease in both
protein synthesis and the total amount of mRNA in fully
grown oocytes.Materials and methods
Msy2 transgene construction, transgenic animal
production, and transgenic mice genotyping
To prepare the vector for MSY2 transgene construction,
the CMV promoter from pEGFP-N2 (Clontech, Palo Alto,
CA) was removed by digestion with AseI and NheI. The
cohesive ends were filled in with Klenow fragment (New
England Biolabs, Inc., Beverly, MA) before self-ligation.
The BglII/NheI fragment containing the CMV promoter
and the chemric intron and the NotI/BamHI fragment
containing the SV40 late polyadenylation signal frompRL-luc vector (Promega, Madison, WI) were then
inserted into the BglII/BamHI, and NotI/DraIII sites of
the modified pEGFP-N2 vector, respectively. To prepare
the MSY2 hairpin, the Msy2 cDNA coding for the entire
cold-shock domain (CSD) and the C-terminal tail domain
(approximately 0.85 kb) were first cloned into the EcoRI/
EagI sites of pET-28a (+) vector (Novagen, Madison, WI),
and the EcoRI/SpeI sites of pXT-7 vector, which was a
generous gift from Sergei Sokol, Harvard University. The
BamHI/EagI Msy2 cDNA fragment from pET-28a (+)
vector was then inserted into the BamHI/PstI sites of
pXT-7 vector that already contained Msy2 cDNA between
its EcoRI/SpeI sites. The EcoRI fragment containing the
Msy2 hairpin from the resulting pXT-7 vector was then
cloned into the NotI site of pEGFP-N2 with the aforemen-
tioned modifications. Last, the CMV promoter was
replaced with the Zp3 promoter (BglII/PstI), the generous
gift of Jurrien Dean. The expression of Msy2 hairpin
dsRNA and its effect on Msy2 mRNA level were con-
firmed by microinjecting the construct into the nucleus of
meiotically incompetent oocytes followed by fluorescence
microscopy to detect expression of the EGFP and RT-PCR
analysis for endogenous Msy2 after 24 h of culture.
The insert was separated from the vector by digestion
with BglII/ClaI and purified as described in www.uphs.
upenn.edu/genetics/core-facs/tcmf/. The DNA was resus-
pended to 5 ng/Al in 10 mM Tris, pH 7.4/0.1 mM EDTA,
and submitted to the Transgenic and Chimeric Mouse
Facility (TCMF) at University of Pennsylvania to produce
transgenic B6SJLF1 mice. To generate F1 transgenic mice,
wild-type CF1 females were mated to the founder B6SJLF1
transgenic male mice.
Southern blotting and PCR were used to identify the
transgenic mice. Tail genomic DNA was isolated as de-
scribed in the TCMF’s protocol (www.uphs.upenn.edu/
genetics/core-facs/tcmf/). About 5 Ag genomic DNA from
each tail sample was digested with PstI overnight, and
subjected to standard Southern blotting analysis using EGFP
cDNA as a probe. For PCR screening, modified T7 primer
(pRL-T7): 5VTAATACGACTCACTATAGGCT3V, and EGFP
sequencing primer (EGFP-seqR): 5VCGTCGCCGTCCA-
GCTCGACCAG3V, were used, which would generate a
107-bp DNA fragment. About 400 ng of tail genomic
DNAwas used in a 25-Al PCR reaction. PCR was performed
as follows: an initial denaturation step at 94jC for 5 min
followed by 33 cycles of 94jC for 15 s, 55jC for 30 s, and
72jC for 30 s followed by 72jC for 5 min.
Collection of oocytes and MII eggs
Meiotically incompetent oocytes (55 Am in diameter),
fully grown oocytes (78 Am in diameter), and ovulated MII
eggs were collected from the transgenic female mice (CF1x
B6SJLF1) as previously described (Brower et al., 1981;
Eppig, 1977). Oocytes were matured in vitro in CZB
medium (Chatot et al., 1989). The zona pellucida (ZP)
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solution (pH 2.5).
Reverse transcription (RT)-PCR and real-time PCR
For semi-quantitative RT-PCR, RNA was extracted and
reverse transcribed as previously described (Temeles et al.,
1994). About 0.05 pg/oocyte globin mRNA was added
before RNA extraction to normalize for RNA extraction
and RT-PCR efficiency. The Msy2 primers used were
msy2F2: 5V CAGCCTATAGCCGCAGAGAC 3V and
msy2R2: 5VGGTGATGCCTCGGAACAATA 3V, which am-
plify a 302 bp sequence in the 3Vend region of Msy2. The a-
globin primers used were F: 5V ACCACCAAGACC-
TACTTTCCT 3V, and R: 5V GTCAGCACGGTGCTCA-
CAGA 3V, which gives a 257-bp fragment. The PCR
amplification conditions were the same for both Msy2 and
a-globin: an initial denaturation at 94jC for 5 min, followed
by 32 or 33 cycles of 94jC for 15 s, 55jC for 30 s, and
72jC for 1 min, followed by 72jC for 5 min. The PCR
products were run on a 1.5% agarose gel.
For real-time PCR of Msy2 and Msy4, total RNA was
isolated from 50 transgenic and control fully grown
oocytes (three samples per group) with the Absolutely
RNA Microprep Kit (Stratagene, La Jolla, CA), and
reverse transcription was carried out with the RETRO-
script Kit (Ambion, Austin, TX). Rabbit globin mRNA
(0.03 pg/oocyte) was added to each sample before RNA
extraction to normalize for RNA extraction and reverse
transcription efficiency. One oocyte equivalent of cDNA
was used in each real-time PCR analysis, which was
carried out with Sybr Green PCR Master Reagents and
7700 sequence detector (PE Applied Biosystems). Stan-
dard curves were constructed using cloned PCR product
as templates. The primers used for both real-time PCR
and template production were as follows: for Msy2, the
forward primer was 5VCATCCTTATTGTTCCGAG-
GCA3Vand the reverse primer was 5VGGAGGTATGA-
GCTGGCTGGTT3V; for Msy4, the forward primer was
5VGACCAAGGCAGGTGAAGCAC3V and the reverse
primer was 5VTCACTCGGCACTGCTCTGTT3V; and for
a-globin, the forward primer was 5VGCCTCCCTGGAC-
AAGTTCCT3V and the reverse primer was VGGCTCC-
AGCTTAACGATATTTGG3V. PCR conditions were as
follows: an initial denaturation step at 95jC for 10 min,
followed by 40 cycles of 95jC for 15 s, and 60 jC for
60 s. Each sample was analyzed in duplicate. The
relative expression level of each gene was calculated
using the standard curve before normalization to globin
mRNA. The specificity of primers was confirmed with
gel electrophoresis.
Immunoblotting
Oocyte extracts were run on a SDS-PAGE gel (9% for
MSY2, 12% for the oocyte-specific histone H1oo) andtransferred to Immobilon P (Millipore, Bedford, MA) The
membranes were processed and developed as previously
described (Yu et al., 2001). The a-MSY2 was used in
1:2000 dilution (Yu et al., 2002); a-H1oo (a gift from Eli
Adashi, University of Utah, Health Sciences Center, Salt
Lake City, UT) was used at a 1:1000 dilution.
IVF and calcium oscillation
In vitro fertilization (IVF) of cumulus cell-free eggs was
carried out as previously described (Moore et al., 1993). To
monitor changes in intracellular Ca2+ following insemina-
tion, ZP-free eggs were incubated in Whitten’s medium
(Whitten, 1971) containing 0.01% PVA (average Molecular
weight 30,000–70,000), 10 AM fura-2-AM (Molecular
Probes Inc., Eugene, OR) and 0.025% Pluronic F-1 (Mo-
lecular Probes) at 37jC in an atmosphere of 5% CO2 in a
humidified chamber for 20 min. The fura-2 loaded eggs
from both control and experimental groups were transferred
to the same 10 Al drop of Whitten’s medium containing no
BSA and placed on a temperature-controlled microscope
stage under laminar flow of 5% CO2 in air. After the eggs
settled, 10 Al of Whitten’s medium containing 30 mg/ml
BSA and 2  105 sperm was gently added to the egg drop.
For Ca2+ imaging, the cells were illuminated using a 100-W
xenon arc lamp; light output was passed through a Lambda
10–2 filter wheel (Sutter Instrument Co., Novato, CA) to
alternate excitation wavelengths between 340 and 380 nm.
Emitted light passed through a fura-2 bandpass filter cube
and was recorded using a Princeton Instruments MicroMAX
CCD camera (Roper Scientific, Trenton, NJ). The emitted
fluorescence was averaged for each egg, and the 340/380
emission ratios were analyzed to determine alterations in
intracellular Ca2+ using MetaFluor software (Universal
Imaging Corp., West Chester, PA). Sperm from B6SJLF1
IVF males were used in all experiments.
ZP2 conversion
Following 2 h in vitro insemination, the zona pellucida
(ZP) was isolated from both transgenic and control eggs as
previously described (Kurasawa et al., 1989). The conver-
sion of ZP2 to ZP2f in individual ZP was analyzed by a
biotinylation-enhanced chemiluminescent assay (Moos et
al., 1994).
Immunofluorescence and confocal microscopy
Immunofluorescence and confocal microscopy of ZP-
free eggs were carried out as previously described (Yu et al.,
2001). For tubulin staining, a-h tubulin (type I, mouse,
1:500, Sigma, St. Louis, MO), and Alexa 488 goat-anti
mouse secondary antibody (1:500, Molecular probes) were
used. For cortical granule (CG) staining, the eggs were first
blocked with PBS/3 mg/ml BSA/0.1 M glycine for 15 min
before permeabilization. The lectin, Lens culinaris aggluti-
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CA) and Texas Red-avidin (1:500, Vector Laboratories)
were used to stain the CG as previously described (Connors
et al., 1998). For DAPI staining, cells were directly mounted
in 0.5 Ag/ml DAPI (Sigma)/Vector Shield (Vector Labora-
tories) solution.
Two-dimensional gel electrophoresis
Oocytes and MII eggs were cultured CZB (-glutamine, F
0.2 mM 3-isobutyl-1-methylxanthine (IBMX)) containing
[35S]methionine [ 1 ACi/Al, 1500 Ci/mmol, Amersham) at
37jC in an atmosphere of 5% CO2 for 3 h. Total oocyte and
MII egg protein extracts containing the same number of
oocytes and eggs were then subjected to two-dimensional
gel electrophoresis using the Investigator 2-D Electropho-
resis System (Millipore) according to the manufacturer’s
instructions. Radiolabeled proteins were detected by expos-
ing the dried gels to the phosphorimager for 1 week, and
scanned with Storm 860 system.
RiboGreen RNA quantification and relative rate of protein
synthesis
Total poly(A) mRNAs were isolated from 100 transgenic
or control fully grown oocytes with Dynabeads mRNA
DIRECTk kit according to the manufacturer’s instructions
(Dynal A.S., Olso, Norway). Quantification of RNA was
carried out with RiboGreen kit(R-11490, Stratagene); E. coli
16S and 23S rRNA that is provided by the manufacturer
was used to construct the standard curve.
Relative rates of protein synthesis were determined as
previously described (Poueymirou and Schultz, 1987). The
data were expressed as a ratio of the number of cpm in the
acid-insoluble fraction/number of cpm in the acid-insoluble
+ acid-soluble fractions and the fraction obtained from the
non-transgenic oocytes was set as 100%.Results
Reduced MSY2 expression in transgenic oocytes
To study the function of Msy2 in vivo during oocyte
development, we employed a transgenic RNAi approach to
reduce Msy2 expression in growing oocytes. This approach
has been successfully used to phenocopy the Mos null
mutant and to study the function of maternal CTCF
(Fedoriw et al., 2004) and its advantages described (Stein
et al., 2003b). The transgene generates a hairpin dsRNA that
is driven by the oocyte-specific Zp3 promoter (Fig. 1A),
which is activated at the onset of oocyte growth, and hence
should target the endogenous Msy2 mRNA once growth
initiates. The function of the EGFP DNA is to separate the
intron from the hairpin sequences because previous studies
indicated that the RNAi effect is compromised when theintron is close to the hairpin sequence (Svoboda et al.,
2001). To circumvent the potential of compromised infer-
tility of transgenic female founder mice, transgenic trans-
mitting male founders are mated to wild type females and
oocytes derived from female transgenic offspring are ana-
lyzed; non-transgenic littermates serve as controls (Stein et
al., 2003b).
The presence of the Msy2 transgene was identified by
PCR analysis of the tail genomic DNA (Fig. 1B). Southern
blot analysis revealed that multiple copies of the transgene
were present in the transgenic founder mice (data not
shown). From the forty-four founder mice, 15 transgenic
females and nine transgenic males were identified, all of
which appeared healthy. Two of the nine transgenic male
founders transmitted the transgene. For one of these male
founder males, little reduction in the amount of MSY2
protein, as detected by immunoblotting, was observed in
oocytes isolated from transgenic female offspring (data not
shown). When the other transgenic transmitting founder
male was mated to a wild-type female, oocytes isolated
from transgenic female offspring contained a reduced
amount of Msy2 mRNA and MSY2 protein (by at least
60%) when compared to non-transgenic littermates (Figs.
1C and D). The decrease in Msy2 mRNA was specific
because real-time PCR analysis revealed at least a 95%
decrease for Msy2 mRNA between transgenic and non-
transgenic oocytes, whereas there was no detectable mRNA
decrease for two other Y-box proteins, Msy4 (Fig. 1E) or
Msy1 (data not shown). The lack of any apparent reduction
in Msy1 and Msy4, which contain the highly conserved
cold-shock domain and are expressed in the oocyte (Gior-
gini et al., 2001; Paynton, 1998), was consistent with the
high inherent specificity of RNAi (Hamada et al., 2002),
and the absence of an RNA-dependent RNA polymerase
amplification mechanism that would target related mRNAs
(Schwarz et al., 2002; Stein et al., 2003a). In addition, there
was no apparent decrease in the amount of the oocyte-
specific histone H1oo protein in the transgenic oocytes
when compared to that present in oocytes obtained from
non-transgenic littermates (Fig. 1D). When F1 transgenic
females were mated to wild-type males, oocytes obtained
from transgenic female F2 offspring also displayed a similar
60% reduction in the amount of MSY2 protein (Fig. 1D).
Similar results were also observed when F1 transgenic
males were mated to wild-type females and the amount of
MSY2 protein was measured in oocytes obtained from
transgenic female F2 offspring (data not shown). Results
of these experiments demonstrated that the transgenic RNAi
approach resulted in a specific reduction of MSY2 protein
by at least 60%.
Decreased fertility in transgenic female mice
We previously proposed that MSY2 is a global and
positive modulator of oocyte mRNA stability (Yu et al.,
2001, 2002, 2003). The decreased amount of Msy2 mRNA
Table 1
Effect of reduced Msy2 expression on ovulation, fertilization, and
development
Transgene Litter size Fertilization
(%)
PN
formation
(%)
2-cell
formation
(%)
No. of
ovulated
eggs
 12.5 F 0.5
(4)
87.4 F 5.1
(52)
85.0 F 6.9
(96)
78.9 F 4.7
(96)
32.8 F 4.3
(17)
+ 2.5 F 1
(4)
85.0 F 9.5
(51)
29.2 F 5.2
(58)
11.9 F 4.1
(58)
16.4 F 2.9
(16)
Four transgenic and four control mice were used to test litter size.
Pronucleus (PN) formation and 2-cell formation were measured 8 and
24 h post-insemination. The numbers of cells/embryo analyzed are in
parentheses. Seventeen control mice and sixteen transgenic mice (> 6
weeks) were superovulated (injectedwith PMSG and hCGwith 48 h interval)
and scored for the number of MII eggs ovulated. All the differences
are significant (P < 0.004, t test) except for the incidence of fertilization
(P = 0.89).
Fig. 1. Characterization and specificity of targeting of expression of Msy2 hairpin-encoding transgene. (A) Msy2 transgenic construct (4761 bp). The Zp3
promoter is about 1.6 kb; the MSY2 hairpin has 1.7 kb with a 247-bp loop. The SV40 late polyadenylation signal was included at the end. (B) Tail sample
screening by PCR using primers in the intron and the EGFP coding region. Shown is the 107-bp expected DNA fragment. (C) RT-PCR analysis of Msy2
mRNA levels in control and transgenic oocytes. RT-PCR conditions were such that the amount of product generated is in the linear range of semi-log plots of
the amount of product vs. cycle number. Globin mRNAwas added to the samples before RNA extraction for normalization for both RNA extraction and RT-
PCR efficiency (Temeles et al., 1994). (D) Immunoblot analysis of MSY2 protein level in control and transgenic oocytes. Control and transgenic oocyte protein
extracts were made from F1 or F2 mice descended from F1 transgenic female mice (20 oocytes for MSY2; 39 oocytes for H1oo). (E) Real-time PCR analysis of
Msy2 and Mys4. TG; transgenic oocytes; non-TG, non-transgenic oocytes.
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females could lead to perturbations in oocyte development,
which in turn could result in females of compromised
fertility. In fact, such was the case. When mated to wild-
type males, the transgenic F1 females (derived by mating
the transgenic male founder to wild-type females) gave birth
to significantly smaller-sized litters with an average of 2.5,
while their non-transgenic littermates had an average litter
size of 12.5 (Table 1). The reduced litter size and other
phenotype traits described below were unlikely due to the
site of transgene integration because we noted that a founder
transgenic female mice was totally infertile and oocytes
recovered from this female revealed a >90% decrease in
MSY2 protein when compared to non-transgenic littermates
(data not shown).
The reduced fertility could be attributed to several
factors, including failure of the oocytes to mature correctly,
a lower incidence of fertilization, failure of inseminated
eggs to undergo appropriate egg activation, or developmen-
tal arrest during either pre- or post-implantation develop-
ment. Accordingly, we examined several of these factors.
Ovulated transgenic and non-transgenic eggs were in-seminated in vitro and development in vitro was monitored.
Although there was no change in the incidence of insemi-
nation, as determined by DAPI staining, there was a
significant decrease in the incidence of pronucleus (PN)
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scored at 8 and 24 h after insemination in vitro, respectively
(Table 1). The 85% (11.9/78.9) reduction in the fraction of
transgenic embryos developing to the 2-cell likely accounts
for the 80% (2.5/12.5) reduction in litter size.
The observation that the transgenic eggs were insemi-
nated but PN formation was markedly inhibited suggested
that the inseminated transgenic eggs failed to undergo ap-
propriate egg activation. In the mouse, fertilization results in
a series of oscillations in the concentration of cytosolic-free
Ca2+, which is necessary and sufficient to cause the MIIFig. 2. Calcium oscillations following insemination of transgenic and non-trans
Metafluor system permits the analysis of calcium oscillations in all of the eggs pre
eggs. The experiment was repeated three times and at least 10 eggs in each gro
experiment and representative calcium tracings from one experiment are shown.eggs to enter anaphase and complete meiosis (Schultz and
Kopf, 1995). The increase in cytosolic-free Ca2++ also
causes cortical granule (CG) exocytosis, which results in
the cleavage of ZP2 (120 kd) to ZP2f (90 kd), and estab-
lishes the ZP block to polyspermy (Wassarman et al., 2001).
Accordingly, each of these endpoints of egg activation was
examined in inseminated transgenic eggs.
The majority of the inseminated transgenic eggs failed
to undergo normal Ca2+ oscillations (Fig. 2C); we noted
that approximately 45% failed to exhibit any Ca2+ oscil-
lations and another 35% displayed a partial response, forgenic eggs. MII-arrested eggs before (A) and post-insemination (B). The
sent in the field. (C) Representative tracing for three transgenic and control
up were used for each experiment. Similar results were obtained for each
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transgenic eggs to carry out Ca2+ oscillations correlated
well with their aberrant morphology, that is, eggs that had
dark granules had very few oscillations, while the eggs
with relatively normal morphology had more oscillations.
Consistent with this result, DAPI staining of the transgenic
eggs 2 h after in vitro insemination showed that the
majority of transgenic eggs still remained at MII, while
the control eggs entered anaphase (Fig. 3A). The increased
staining of CGs seen in fertilized transgenic eggs, when
compared to inseminated non-transgenic eggs, indicated a
failure of the transgenic eggs to undergo CG exocytosis,
which was confirmed by monitoring the conversion of ZP2
to ZP2f (Fig. 3B). Following 2 h of in vitro insemination,
ZP2 from the control eggs showed increased electropho-
retic mobility, which indicated cleavage of this protein,
while those from the transgenic eggs had the same
mobility as that from MII eggs. The failure of transgenic
eggs to undergo CG exocytosis and ZP2 conversion is the
likely explanation for the polyspermy seen in the fertilized
transgenic eggs (data not shown).Fig. 3. Cell cycle resumption, cortical granule exocytosis, and ZP2 conversion in
enter anaphase and undergo cortical granule exocytosis. DNA staining (DAPI, gree
in vitro insemination. The arrows point to either the sperm (Sp) or egg (MII) DNA
entry into anaphase, whereas in inseminated transgenic eggs the egg chromosome
was conducted three times and similar results were observed in each experiment; sh
transgenic and control eggs following 2 h of in vitro insemination and then process
of the biotinylation reaction for that sample.The reduced number of Ca2+ oscillations following in-
semination of transgenic eggs may be due to a reduced size
of the intracellular Ca2+ pool. Thapsigargin inhibits endo-
plasmic and sarcoplasmic reticulum Ca2+-ATPases, but not
plasma membrane Ca2+-ATPases and hence increases cyto-
plasmic Ca2+ by preventing Ca2+ reuptake (Lytton et al.,
1991; Sagara and Inesi, 1991; Thastrup et al., 1990). Trans-
genic eggs treated with thapsigargin release less Ca2+ than
their non-transgenic counterparts (Fig. 4A). Consistent with
a markedly reduced store of intracellular Ca2+ is that trans-
genic eggs treated with Sr2+ resulted in only a single Ca2+
transient, whereas non-transgenic eggs displayed a normal
series of Ca2+ oscillations (Figs. 4B and C).
Morphology, chromatin configuration, and meiotic spindle
formation in transgenic oocytes
As described above, many of the ovulated transgenic
eggs possessed dark granules (Figs. 2A and B). This led us
to examine transgenic oocytes and eggs more carefully.
Both fully grown oocytes and MII eggs isolated from thetransgenic and non-transgenic eggs. (A) Fertilized transgenic eggs failed to
n); cortical granule staining (red). The cells were processed following 2 h of
. Note in the control eggs the separation of the egg chromosomes, indicating
s remained condensed with no sign of entry into anaphase. The experiment
own are representative images. (B) ZP2 conversion. ZPs were isolated from
ed for ZP2 conversion. The lack of a signal in lane 6 likely reflects a failure
Fig. 4. Changes in intracellular Ca2+ concentration in transgenic and non-
transgenic oocytes following either thapsigargin or Sr2+ treatment.
Transgenic oocytes (A) and non-transgenic oocytes (B) were incubated in
medium containing 10 mM Sr2+ to induce changes in intracellular Ca2+.
The experiment was repeated two times and at least 10 eggs in each group
were used for each experiment. Similar results were obtained for each
experiment and representative calcium tracings from one experiment are
shown. (C) Transgenic and non-transgenic eggs were incubated in medium
containing 50 AM thapsigargin and changes in intracellular Ca2+ concen-
tration were measured. The experiment was repeated two times and at least
10 eggs in each group were used for each experiment. Similar results were
obtained for each experiment and representative calcium tracings from one
experiment are shown.
Fig. 5. DNA configuration and spindle formation in transgenic oocytes. (A)
Examples of SN and NSN-type chromatin configuration in fully grown
transgenic oocytes. DNA staining (DAPI, green); tubulin staining (red). The
arrow points to the region of condensed chromatin that surrounds the
nucleolus. (B) MII spindle formation following maturation in vitro for 18 h.
The experiment was performed three times and similar results were
obtained in each case; shown are representative images. For staining of GV-
intact oocytes, 81 control and 93 transgenic oocytes were analyzed,
respectively; the increased incidence of the NSN configuration is significant
(P < 0.02). For staining of MII eggs, 65 control and 81 transgenic eggs were
analyzed; the increased incidence of abnormal spindle formation is
significant (P < 0.005).
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appeared morphologically abnormal (data not shown).
Many of the transgenic oocytes looked darker than the
controls, and this appeared even more pronounced in the
transgenic MII eggs. The number and size of the oocytes
isolated from the transgenic females were similar to thosefrom the non-transgenic controls. The number of MII eggs
collected from the superovulated transgenic females, how-
ever, was consistently lower than that from their non-
transgenic littermate controls (Table 1).
Fully grown GV-intact oocytes exhibit two types of
nuclear DNA configurations that differ by the presence or
absence of a ring of condensed chromatin around the
nucleolus. These configurations have been termed SN
(surrounded nucleolus) and NSN (non-surrounded nucleo-
lus) (Fig. 5) (Bouniol-Baly et al., 1999). While all the
oocytes are of the NSN or partial NSN (pNSN) configu-
rations in mice before 15 days after birth, the percentage of
oocytes with the SN configuration increases with age and
J. Yu et al. / Developmental Biology 268 (2004) 195–206 203increasing oocyte diameter. The SN-type oocytes display
dramatically reduced levels of RNA polymerase I- and II-
dependent transcription, while the NSN-type oocytes are
actively transcribing (Bouniol-Baly et al., 1999; De La
Fuente and Eppig, 2001). DAPI staining indicated a signif-
icantly higher percentage of NSN chromatin configurations
in the fully grown transgenic oocytes. Most of the control
oocytes (68%, n = 81) had a SN-type configuration, while
only 35% of the transgenic oocytes (n = 93) displayed such
a configuration (Fig. 5A). This suggests that the majority of
the fully grown transgenic oocytes may not have developed
properly and this would consequently impact negatively on
their ability to undergo meiotic maturation and egg activa-
tion following fertilization.
To find out whether meiotic maturation occurs normally
in transgenic oocytes, in vitro maturation (IVM) was carried
out. Although all of the transgenic eggs contained con-
densed chromosomes, following 18 h of IVM 69% of them
contained either an abnormal spindle, or a spindle that
displayed markedly reduced tubulin staining. In contrast,
only 2% of the control eggs displayed an abnormal spindle
(Fig. 5B). The spindle effect was even more pronounced in
the transgenic female founder that was analyzed, in which
virtually all of the matured oocytes displayed condensed
chromosomes but no visible spindle (data not shown); theFig. 6. Two-dimensional gel analysis of protein synthesis in control and Msy2 tra
containing polypeptides that display the maturation-associated changes in both
representative of maturation-associated changes that do not occur in the transgenic
and reveals that the maturation-associated changes in spindlin do not occur in theincreased severity of this phenotype was consistent with the
greater reduction of MSY2 protein in these oocytes.
Protein synthesis and mRNA content in transgenic oocytes
We have proposed Msy2 to be a global regulator of
maternal mRNA stability (Yu et al., 2001, 2002, 2003). If
such were the case, a reduction in the amount MSY2 protein
would result in a decrease in both the amount of mRNA and
protein synthesis in the fully grown oocyte. Quantification of
total isolated poly(A) mRNA using RiboGreen indicated a
decrease of approximately 25% in the transgenic fully grown
oocytes when compared to non-transgenic oocytes (62.03 F
4.46 pg/oocyte vs. 80 F 5.69 pg/oocyte, where measure-
ments were made on 10 transgenic and 8 non-transgenic
samples; P < 0.05, t test). The value of 80 pg of poly (A)
mRNA/oocyte we obtained for non-transgenic oocytes using
this method is in excellent agreement with the value of 80 pg/
oocyte previously reported (Bachvarova et al., 1985).
Transgenic oocytes and metaphase II-arrested eggs also
displayed reduced levels of protein synthesis as evidenced
by the decrease in the overall staining intensity following
two-dimensional gel electrophoresis, consistent with the
global reduction in the amount of mRNA (Fig. 6). Consis-
tent with this finding is that incorporation of [35S]methi-nsgenic oocytes and MII eggs. The arrows point to representative regions
control and transgenic oocytes. The polypeptide(s) in the rectangles is
oocytes. The thick arrow points to the region of the gel containing spindlin
transgenic oocytes.
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imately 55% in the transgenic oocytes, when compared to
non-transgenic oocytes. Although the relative rate of syn-
thesis of many polypeptides was reduced, that of others
appeared unaffected in both oocytes and eggs. In addition,
many of the maturation-associated changes in protein syn-
thesis did not occur during maturation of transgenic oocytes,
including spindlin (Oh et al., 1997). This failure may
account for the reduced fertilization potential of the trans-
genic eggs.Discussion
We report here that reducing the amount of MSY2
protein expression in oocytes by a transgenic RNAi ap-
proach results in a marked reduction in fertility that is likely
attributable to the production of ‘‘low quality’’ eggs. Al-
though these eggs can be inseminated, they do not undergo
appropriate egg activation responses (e.g., intracellular Ca2+
oscillations, cell cycle resumption, cortical granule exocy-
tosis, and ZP modifications) and hence arrest predominantly
at the 1-cell stage. Consistent with our previous proposal
that Msy2 is a global regulator of maternal mRNA stability
the amount of total mRNA is reduced approximately 20–
25% in fully grown transgenic oocytes. This global reduc-
tion in maternal mRNA presumably is responsible for the
altered morphological appearance of the oocytes, and the
widespread decrease in protein synthesis and maturation-
associated defects, for example, absence of several of the
maturation-associated changes in protein synthesis and
defective spindle formation. Of interest is that the matura-
tion-associated changes in spindlin are not observed in the
transgenic oocytes. Spindlin, which is a substrate for MAP
kinase (Oh et al., 1998), associates with the spindle (Oh et
al., 1997), and the failure of these maturation-associated
changes in spindlin synthesis to occur may account, at least
in part, for the abnormal spindles that develop during
maturation of the transgenic oocytes.
We have previously used a transgenic RNAi approach to
target Mos to demonstrate the feasibility of this approach
and observed that we could phenocopy the Mos null mutant,
that is, the eggs did not arrest at metaphase II but undergo
spontaneous activation at a high frequency due to a failure
to activate MAP kinase (Stein et al., 2003b). One reserva-
tion about the generality of this approach is that Mos mRNA
is not translated until meiosis resumes in the fully grown
oocyte (Gebauer and Richter, 1997). Thus, the RNAi
mechanism would have the entire period of oocyte growth
to target the endogenous Mos mRNA. The results presented
here and elsewhere (Fedoriw et al., 2004) strongly suggest
that this transgenic RNAi approach should be suitable to
study the function of any gene in the oocyte, even genes that
encode for abundantly expressed transcripts. MSY2 is one
of the most abundant proteins in the oocyte, constituting
approximately 2% of total oocyte protein (Yu et al., 2001).Msy2 mRNA is likely to be a very abundant transcript
because there is in general an excellent correspondence
between amount of protein and mRNA abundance. In
addition, MSY2 is synthesized throughout oocyte growth
and its concentration remains essentially constant (Yu et al.,
2001).
Oocytes (and preimplantation embryos) are ideally suited
for the transgenic RNAi approach using long dsRNA.
Although oocytes and preimplantation embryos possess
the apoptotic machinery (Brison and Schultz, 1997; Juris-
icova et al., 1998), long dsRNA does not elicit the apoptotic
response observed in somatic cells due to inhibiting global
protein synthesis (Svoboda et al., 2000). Nevertheless,
developing transgenic oocytes are exposed to dsRNA for
longer periods of time than previously used. Hence, it is
formally possible that the Msy2 dsRNA activated PKR,
which in turn phosphorylated and activated eIF2a. dsRNA
can also stimulate 2V–5VoligoA synthetase to produce a series
of short 2V, 5V-oligoadenylates that activates RNase L which
then cleaves single-stranded RNA (Clemens and Elia, 1997;
Stark et al., 1998). Either or both of these processes would
result in a decrease in protein synthesis and total mRNA
abundance and lead to the observed deficiencies in oocyte
maturation and fertilization. Several lines of evidence argue
against this scenario. First, transgenic oocytes expressing
Mos dsRNA or Ctcf dsRNA appear morphologically normal
and are able to mature successfully to metaphase II (Fedoriw
et al., 2004; Stein et al., 2003b). Results of immunoblotting
experiments reveal that the concentration of PKR in oocytes
(and blastocysts) is at most 3% that of somatic cells (Stein
and Schultz, unpublished observations). Moreover, the con-
centration of eIF2a in oocytes is approximately 4% that of
somatic cells and the same fraction of the active phosphor-
ylated form of eIF2a is present in both transgenic and non-
transgenic oocytes (Yu, Hecht, and Schultz, unpublished
observations). Last, in the transgenic oocytes, we do not
observe any substantial decrease in either Msy1 or Msy4,
implying that the RNase L-mediated mRNA degradation
pathway is not activated. Likewise, in transgenic oocytes
expressing eitherMos or Ctcf dsRNA, there was no decrease
in non-targeted mRNAs (Fedoriw et al., 2004; Stein et al.,
2003b).
We obtained the same number of oocytes from trans-
genic and non-transgenic females and these oocytes were
of similar diameter. Nevertheless, significantly fewer ovu-
lated transgenic eggs were obtained. It is unlikely that
faulty maturation of transgenic oocytes (e.g., high inci-
dence of correct spindle formation and absence of many of
the maturation-associated changes in protein synthesis) is
the cause for the lower extent of ovulation. In Cdc25b
knockout mice, oocytes fail to resume meiosis, but hor-
mone stimulation results in similar numbers of ovulated
GV-intact oocytes (Lincoln et al., 2002). Likewise, inhibit-
ing the oocyte-specific cyclic nucleotide phosphodiesterase
PDE-3 results in ovulation of a similar number of GV-
intact oocytes (Wiersma et al., 1998). Defects in follicle
J. Yu et al. / Developmental Biology 268 (2004) 195–206 205cell–oocyte communication, however, could be responsi-
ble. A growing body of evidence indicates that the oocyte
and follicle cells communicate bi-directionally via both gap
junctions and secretory mechanisms (Matzuk et al., 2002).
Compromised oocyte development in the transgenic
oocytes could result in follicles with a diminished response
to hormonal stimulation.
The increased incidence of the NSN DNA chromatin
configuration in transgenic oocytes may also reflect per-
turbations in oocyte–follicle cell bidirectional signaling.
The SN DNA configuration is not observed when denuded
oocytes isolated from 12-day-old mice are cultured for 4
days (De La Fuente and Eppig, 2001). In contrast, then
oocyte–granulosa cell complex isolated from 12-day-old
mice are cultured for 4 days, the SN staining pattern
develops. Moreover, transcription remains elevated in the
cultured denuded oocytes, whereas it displays a pro-
nounced decrease when the oocytes are associated with
the granulosa cells. If there is a direct linkage between
formation of the SN DNA staining pattern and decreased
transcription, transcription may continue at elevated levels
in the transgenic oocytes. Such dysregulated transcription
could contribute to the formation of fully grown oocytes
with reduced meiotic and developmental competence.
Last, the increased incidence of the NSN DNA configu-
ration in the transgenic oocytes that is associated with a
decreased ability to mature to metaphase II and then
activate following insemination is similar to the reduced
ability of fully grown oocytes that exhibit the NSN
phenotype to complete maturation and become activated
following Sr2+ treatment (Liu and Aoki, 2002). Current
studies are addressing follicle cell–oocyte communication
in the transgenic females.
The abundance of MSY2 protein to oocyte mRNA (a
calculated molar ratio of about 70:1, (Yu et al., 2001)) and
the concatameric properties of MSY2 (Yu et al., 2002)
suggest that many of the oocyte mRNAs are bound by
multimers of MSY2. The reduction of MSY2 protein
levels by our transgenic RNAi approach creates a defi-
ciency in MSY2 protein that drastically reduces fertility,
while modestly reducing the total mRNA level. This
reduction should lead to mRNAs lacking or with reduced
amounts of MSY2 protein. To date, little is known of the
MSY2 protein/mRNA ratios needed for individual mRNAs
to maintain their stability. This reduction likely differen-
tially affects mRNAs because similar but not identical
patterns of protein synthesis are seen in control and
transgenic eggs.
In summary, the results described here provide further
support for Msy2 as a global modulator of maternal mRNA
stability and highlight the robustness of the transgenic
RNAi approach to study gene function in oocyte develop-
ment. Further analyses of knockout and additional knock-
down lines of Msy2-deficient mice will allow a more
detailed understanding of Msy2 function during oocyte
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